MedPath

Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Radiation: Tomosynthesis Breast Scanning
Radiation: Breast CT Scanning
Registration Number
NCT01852032
Lead Sponsor
University of California, Davis
Brief Summary

The purpose of this study is to compare the imaging performance of an investigational breast computed tomography (CT) scanner, built at UC Davis, with that of an FDA-Approved breast tomosynthesis scanner (capable of producing standard 2-D mammography and 3-D tomosynthesis images), built by Hologic, Incorporated, in a group of patients with suspected breast cancer.

Detailed Description

The primary aim of this study is the comparison of Beta values of several different CT and Tomosynthesis views (Beta of CT Sagittal View, Beta of CT Coronal View, Beta of CT Axial View, Beta of Tomosynthesis Craniocaudal View, Beta of Tomosynthesis Medial Lateral Oblique View). Lower Beta values correspond to better image quality (less noise, increased cancer detection).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
23
Inclusion Criteria
  • 35 years of age or older
  • While male patients will not be explicitly excluded, it is expected that all patients in this study will be women
  • Diagnostic findings from prior mammography suspicious for, or highly suggestive of, breast malignancy -BIRADS (Breast Imaging Reporting and Data System) categories 4 and 5
  • Scheduled for ultrasound or stereotactic core biopsy
  • Ability to lie still on a table top for up to 10 minutes, longer than the typical breast CT duration.
  • Ability to understand risks, procedures, and benefits involved
Exclusion Criteria
  • Recent breast biopsy
  • History of breast augmentation implant
  • Pregnant or Positive urine pregnancy test (UPT) or currently breast-feeding
  • History of moderate or severe adverse reaction to iodinated contrast injection
  • Recent serum creatinine ≥ 1.5 mg/dL
  • History of Diabetes Mellitus
  • Currently taking Glucophage or Glucovance (Metformin)
  • History of chronic asthma
  • History of allergy to iodine
  • Multiple food and/or drug allergy
  • Renal disease
  • History of pulmonary disease, phobia of breath holding, or other condition that could prevent the subject from being able to perform the 16 second breath hold

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Breast cancer PatientsTomosynthesis Breast ScanningTomosynthesis Breast Scanning is done and breast CT Scanning is done.
Breast cancer PatientsBreast CT ScanningTomosynthesis Breast Scanning is done and breast CT Scanning is done.
Primary Outcome Measures
NameTimeMethod
Beta of CT Axial ViewDay 1

frequency range corresponding to noise power spectrum (NPS) where beta = NPS(f) = af\^-B.

beta is calculated as noise corresponding to frequency. The values of the exponent, beta, range from 1.5 to 3.5 Lower Beta values correspond to better image quality (less noise, increased cancer detection).

Beta of CT Coronal ViewDay 1

frequency range corresponding to noise power spectrum (NPS) where beta = NPS(f) = af\^-B.

beta is calculated as noise corresponding to frequency. The values of the exponent, beta, range from 1.5 to 3.5 Lower Beta values correspond to better image quality (less noise, increased cancer detection).

Beta of Tomosynthesis Craniocaudal ViewDay 1

frequency range corresponding to noise power spectrum (NPS) where beta = NPS(f) = af\^-B.

beta is calculated as noise corresponding to frequency. The values of the exponent, beta, range from 1.5 to 3.5 Lower Beta values correspond to better image quality (less noise, increased cancer detection).

Beta of CT Sagittal ViewDay 1

frequency range corresponding to noise power spectrum (NPS) where beta = NPS(f) = af\^-B.

beta is calculated as noise corresponding to frequency. The values of the exponent, beta, range from 1.5 to 3.5 Lower Beta values correspond to better image quality (less noise, increased cancer detection).

Beta of Tomosynthesis Medial Lateral Oblique ViewDay 1

frequency range corresponding to noise power spectrum (NPS) where beta = NPS(f) = af\^-B.

beta is calculated as noise corresponding to frequency. The values of the exponent, beta, range from 1.5 to 3.5 Lower Beta values correspond to better image quality (less noise, increased cancer detection).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UC Davis Medical Center

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath